DQPLHXVWVGFHCR-VGOFMYFVSA-N
C18H16F3N5O2 — CID 121367859
Data last refreshed: (MolForge compound catalog, from PubChem)
About DQPLHXVWVGFHCR-VGOFMYFVSA-N
DQPLHXVWVGFHCR-VGOFMYFVSA-N (PubChem CID 121367859) has the molecular formula C18H16F3N5O2 and a molecular weight of 391.35 g/mol. Its IUPAC name is (E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide.
Molecular Properties
| Compound Name | DQPLHXVWVGFHCR-VGOFMYFVSA-N |
|---|---|
| PubChem CID | 121367859 |
| Molecular Formula | C18H16F3N5O2 |
| Molecular Weight | 391.35 g/mol |
| Exact Mass | 391.13 |
| IUPAC Name | (E)-2-(3,5-dimethyl-1,2-oxazol-4-yl)-3-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide |
| SMILES | Cc1cc(-c2ncn(/C=C(/C(N)=O)c3c(C)noc3C)n2)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C18H16F3N5O2/c1-9-4-12(6-13(5-9)18(19,20)21)17-23-8-26(24-17)7-14(16(22)27)15-10(2)25-28-11(15)3/h4-8H,1-3H3,(H2,22,27)/b14-7+ |
| InChIKey | DQPLHXVWVGFHCR-VGOFMYFVSA-N |
| XLogP | 3.36 |
| TPSA | 99.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 391.35 |
| LogP ≤ 5 | 3.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121367859 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.